Our inclusive multi-marker network-based approach efficiently recovered novel evidence of highly divergent microbial genes, possibly partly originating from microbial dark matter, even in the human gut.
This approach allows us to select disease related genes that are implicated by the genetic marker and network connectivity information.
This approach enabled us to determine the hub genes implicated by both the genetic marker and network connectivity information.
Recent fMRI studies also concluded that contralateral reorganization was not efficient but rather a marker of network disruption due to underlying pathology (Powell et al., 2007).
In this sense, enhanced contralesional fronto limbic coupling can be regarded "as a marker of network disruption in the presence of mesial temporal pathology" (Saling 2009), which is in agreement with previous work (Dupont et al. 2000; Maccotta et al. 2007; Powell et al. 2007; Vlooswijk et al. 2008).
Consistent with this, capsids did not colocalise with either the trans-Golgi network marker TGN46 or late endosomal markers, but showed coincidence with the transferrin receptor.
We also found 134 significant proteins in the specific network marker of early stage bladder cancer and 32 significant proteins in the specific network marker of late stage bladder cancer.
We found that there were 28 significant proteins that could be classified as a core network marker and 26, 4, 24, and 13 significant proteins that were specific network markers of bladder, colorectal, liver, and lung cancer, respectively.
To target PPIs in both common core network markers and specific network markers simultaneously may provide new directions for anticancer therapy strategies.
The markers in the network may each be sensitive markers of inflammatory modulation.
Finally, based on these common core network markers and specific network markers, we investigated the mechanisms behind the carcinogenesis process with the help of databases (for example, GO database [ 23], DAVID database [ 24, 25], and KEGG pathway database [ 26, 27]) to find multiple network targets for cancer therapy.
